Future of Work Survey Report #2: Business requests for new software applications soaring globally, but 50-percent end in failure
European companies make significantly more requests than U.S. companies, but all are held back by technical debt and development complexity
LONDON, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN) today announced the second set of findings from its Future of Work global survey, conducted by IDG. According to the data, European companies are even more overloaded in trying to meet the required pace of digital business transformation than U.S. companies. An average EMEA enterprise generates 230 internal requests for new business software applications and major feature enhancements every year. In Germany that figure is as high as 306, in France it’s 263, and in the U.K. it’s 137. The European average is well above the U.S. figure of 153 requests.
Despite this disparity, global success rates are all equally dismal. Across all surveyed geographies, 50% of all new app development requests end in the failure. They are either not delivered at all, or are delivered without meeting the business need.
The research, being released in a series of reports, examines the state of business transformation and its impact on the future of work. Key findings from the survey of senior IT leaders across the U.S., U.K., Germany, France and Spain include:
- 16% of new development projects requested by EMEA enterprises never get started (compared to 14% in the U.S.)
- 14% of new EMEA development projects are started but never finished (compared to 16% in the U.S.)
- 20% of new development projects in both EMEA and the U.S. are delivered but don’t meet the business need
Digital demand is spreading through the enterprise
Demand for new development projects is now generated across the enterprise, showing that all business units are looking for ways to change how they operate in the Digital Age. In the U.S., marketing is still somewhat more likely than other departments to request new apps, while EMEA skews slightly to finance and accounting. The survey data shows the following breakdown of business unit app development requests in the U.S and EMEA:
- Finance requests 14% (U.S.)/16% (EMEA) of all new applications and features
- Marketing requests 19% (U.S.)/16% (EMEA)
- Sales requests 17% (U.S.)/18% (EMEA)
- Customer service/Contact centers request 16% (U.S.)/17% (EMEA)
- R&D requests 15% (U.S.)/16% (EMEA)
- Legal 11% (U.S.)/10% (EMEA)
- All other departments request a further 7% (U.S.)/8% (EMEA)
Enterprises are piling up technical debt
Across the board, IT departments are struggling – and failing – to meet evolving business requirements, primarily due to the slow pace of coding and issues related to technical debt.
Technical debt is the implied cost of additional rework caused by choosing an easy solution now over the right solution. It also reflects the “lost opportunity” cost of not developing the right application needed to take advantage of a market opportunity. IT organizations spend 50% of their time coding new apps and enhancements - but they lose about two-fifths of their development time to technical debt (39% U.S./36% EMEA). Overall, the global business impact of technical debt is:
- 55% - Higher operational expenses
- 52% - Simple software enhancements take much longer than expected
- 47% - Reduced performance and scalability
- 35% - Longer time-to-market
- 17% - Customer-experience improvements are not made
When asked how to combat technical debt, the number #1 response from survey participants – 53% – was “look for new ways to accelerate application development.”
Enterprise low-code: a new approach
Enterprise low-code development platforms accelerate application creation with robust but easy-to-use drag-and-drop visual design tools. They also ensure that all applications are connected, governed, and future-proof. This gets applications and features to market faster without creating new application silos, or compromising on quality, performance, and experience. As a result, enterprises can minimize technical debt and react quickly in seizing new market opportunities.
“The survey data shows that all companies must accelerate IT development without sacrificing quality or accumulating more technical debt,” said Appian CEO Matt Calkins.
The Future of Work survey, conducted by IDG, gathered responses between August and September 2018. Respondents comprised of 500 IT leaders (50% C-level, all Director or above) with at companies with over 1,000 employees. For this leg of the survey, 50% of respondents were U.S. based, and 50% were from Europe (U.K., France, Germany, and Spain). To qualify for the survey, respondents also had to be undergoing digital transformation efforts for at least one year.
Appian provides a software development platform that combines intelligent automation and enterprise low-code development to rapidly deliver powerful business applications. Many of the world’s largest organizations use Appian applications to improve customer experience, achieve operational excellence, and simplify global risk and compliance.
For Information Contact:
Director of Media Relations
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/3aed1b16-30be-4d30-899e-38c3cf76c6f9
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
WillScot Announces Closing of Warrant Exchange Offer11.12.2018 22:05 | Pressemelding
BALTIMORE, Dec. 11, 2018 (GLOBE NEWSWIRE) -- WillScot Corporation (“WillScot”) (NASDAQ: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced the closing of its previously announced exchange offer (the “Exchange Offer”) relating to certain outstanding warrants issued in 2015 (the “Warrants”). Under the terms of the Exchange Offer, each Warrant holder had the opportunity to receive 0.18182 shares of WillScot Class A Common Stock, par value $0.0001 per share (“Common Stock”), for each Warrant tendered by the holder and exchanged pursuant to the Exchange Offer. As of the closing of the Exchange Offer on December 11, 2018, 45,131,827 outstanding Warrants were properly tendered and not withdrawn in the Exchange Offer. 45,031,827 of the Warrants tendered were public warrants, representing approximately 89% of the public warrants, and approximately 100,000 Warrants tendered were private warrant
DoubleVerify and InMobi Unite to Combat Mobile App Fraud11.12.2018 18:02 | Pressemelding
Partnership brings mobile app fraud prevention to advertisers globally NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- DoubleVerify ("DV"), the leading independent provider of marketing measurement software and analytics, today announced a partnership with InMobi, a global provider of enterprise platforms for marketers. As part of the partnership, DoubleVerify will provide always-on fraud filtering and measurement for mobile in-app advertising campaigns across the InMobi Exchange globally. The integration with InMobi covers pre-bid targeting for all InMobi Exchange impressions within the leading mobile in-app platform, as well as monitoring of post-bid fraud activity, such as spoofing – enabling InMobi to continuously refine the quality of its mobile ad inventory. “DV’s partnership with InMobi demonstrates our commitment to provide consistent, comprehensive quality coverage for global brand advertisers,” said Matt McLaughlin, COO at DoubleVerify. “With ad spend increasingly concentrated in
Claroty Announces Major Enhancements to Market-Leading Industrial Cybersecurity Platform11.12.2018 15:00 | Pressemelding
Groundbreaking multispectral data acquisition and network segmentation capabilities provide deeper OT network visibility and reduce risk for industrial enterprises and critical infrastructure providers NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Claroty, the leader in operational technology (OT) network protection, today announced several significant enhancements to its award-winning Continuous Threat Detection product and technology integrations with several leading industrial automation, network infrastructure and cybersecurity providers. Already the industry’s most complete industrial control systems (ICS) cybersecurity platform, this release incorporates new functionality to provide even more “extreme” visibility into ICS networks and help industrial enterprises decrease the risk of a cyberattack. The latest release of Claroty Continuous Threat Detection provides a large number of significant enhancements including: Virtual Zones and OT Network Segmentation – an innovative approach
INN Launches Battery Metals Channel11.12.2018 15:00 | Pressemelding
The new battery metals channel is designed to educate investors with original content and expert insight on the growing battery metals industry. VANCOUVER, British Columbia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Investing News Network (INN) announces the launch of its battery metals channel. Responding to the growth and evolution of the battery metals market, this channel will host news, educational content and expert opinions on the lithium, cobalt, graphite, vanadium and manganese market segments. “INN has been a trusted source of information on the lithium, cobalt, graphite, vanadium and manganese markets for nearly a decade, and is excited to bring these sectors together under the battery metals umbrella,” said Nick Smith, CEO and publisher at INN. “Through connections with experts, our leading team of experienced writers creates original, insightful content on battery metals. INN educates investors in the industry by providing information they may never have access to on their own,” S
Galimedix Therapeutics Appoints Industry Veteran, Hermann Russ, M.D., Ph.D., Chief Scientific Officer11.12.2018 14:30 | Pressemelding
KENSINGTON, Md. and SHORASHIM, Israel, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Galimedix Therapeutics, which is developing new solutions for ophthalmic and neurodegenerative diseases, announced the appointment of Hermann Russ, M.D., Ph.D., as its chief scientific officer, effective December 1, 2018. Dr. Russ invented the use of the company’s lead molecule GAL-101/MRZ-99030 for the treatment of degenerative diseases of the retina, including glaucoma and dry macular degeneration. He is also co-inventor of the so-called “trigger effect” of GAL-101/MRZ-99030 and GAL-102/MRZ 14042, which is a unique reverse prion-like self-propagation mechanism of action important for the company’s eye drop and oral treatment regimens. “We are gratified that Dr. Russ is joining the Galimedix management team, as his knowledge in the field, as well as intimate experience with the compound, have already proven instrumental in the development of our company to date,” commented Andrew Pearlman, Ph.D., CEO of Galimedix
Farmako: Cannabis distributor to become gateway to Europe11.12.2018 10:00 | Pressemelding
Company is first to apply for a licence in the United Kingdom AAA-Team pushes to become gateway to Europe Company first to apply for distribution licences in UK Support of Canadian LP to obtain EU-GMP Focus on research and development FRANKFURT, Germany, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The Frankfurt-based pharmaceutical company Farmako is a research-based pharmaceutical company that distributes medical cannabis. The company is active in all European markets that have created a legal basis for cannabinoid therapies. It is the first company for medical Cannabis pursue distribution licences in multiple European countries. Fort hat, it will rely on EU-GMP certified suppliers. The German market for medical cannabis is estimated at 19.1 million euros in 2018 and at 200 million Euros by 2019. For 2028, experts expect a market volume for medical cannabis of 7.8 billion euros in Germany, an increase by a factor of 400. The number of patients for cannabinoid therapies in Germany has grown from
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom